Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

RBC reports for 3 months of 2024 by RAS

5/28/24 RBCM

Board of Directors of Phosagro recommended that dividends be paid for 3 months 2024

5/28/24 PHOR

Board of Directors of Phosagro recommended that dividends be paid for 2023

5/28/24 PHOR

JetLend is gearing up for Pre-IPO

5/28/24 OTCI

Ozon will build a warehouse complex in Dagestan

5/28/24 OZON

Yandex.Market expands fullfillment center in Rostov-on-Don

5/28/24 YDEX

Sollers may start production of minivans

5/28/24 SVAV

Gazprom Neft started production at block 3A of the Achimov deposits

5/28/24 SIBN

Board of Directors of Ufaorgsintez recommended that dividends be paid for 2023

5/28/24 UFOSP

Alrosa reported for 3 months of 2024 by RAS

5/28/24 ALRS